M&A deals in biotech companies in Spain are on the rise

07/10/2014
Diego Gutiérrez
M&A deals in biotech companies in Spain are on the rise
Biotech companies in Spain are becoming more attractive to corporate investors. In some sectors, integration processes are taking place, such as that of Grifols. In other cases, the stock market is becoming an alternative for the biotechnology sector.

 

More than 50 companies acquired since 2008

The level of mergers and acquisitions produced in the biotechnology sector in Spain has maintained very stable levels from 2010 to 2013. This first half of 2014 has seen an upturn with 7 deals. A good track record of success for investors is important for the sector in order to attract more capital to finance Spanish biotech companies.

The stock market becomes an alternative exit route for investors

Few Spanish companies have gone public in the last few years. Bag since Zeltia was floated on the continuous market in 1991. In 2006 it was Grifols, followed by Almirall and Rovi in 2007. But the emergence of the MAB has enabled smaller biotech companies to access investment to finance the development of their drugs and products. It was the companies Neuron and AB-BIotics that launched the new alternative market in June 2010.

Other related links:

List of investors in biotech companies in Spain

List of investors in biomarker biotechnology

mergers and acquisitions-en-biotecnologia-en-espana/">List of mergers and acquisitions en biotecnología de biomarcadores

 

We are currently preparing a report on the current state of crowdfunding as an alternative means of financing. If you are interested in receiving this report, leave us your email address and we will send it to you once it has been prepared.

 

 

Lastest news

The State of Technology M&A in Spain | October 2026 analysis

En octubre de 2026 hubo 37 operaciones de M&A tecnológico en España: 16 fueron adquisiciones corporativas, inversiones de private equity, fusiones o tomas de participación, y 21 fueron rondas de venture capital. El 62,2% de las operaciones (23 de 37) fueron...

Webinar | How much does your business depend on you?

IMPORTANT INFORMATION: Registration for and participation in the webinars are completely anonymous to third parties. If, for a month, you were unable to have a say in important decisions, what would happen in your company? Your company can grow, be profitable and have good...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?